These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
498 related articles for article (PubMed ID: 26576481)
21. Hepatitis B Virus Infection of HepaRG Cells, HepaRG-hNTCP Cells, and Primary Human Hepatocytes. Ni Y; Urban S Methods Mol Biol; 2017; 1540():15-25. PubMed ID: 27975304 [TBL] [Abstract][Full Text] [Related]
22. Down-regulation of cell membrane localized NTCP expression in proliferating hepatocytes prevents hepatitis B virus infection. Yan Y; Allweiss L; Yang D; Kang J; Wang J; Qian X; Zhang T; Liu H; Wang L; Liu S; Sui J; Chen X; Dandri M; Zhao J; Lu F Emerg Microbes Infect; 2019; 8(1):879-894. PubMed ID: 31179847 [TBL] [Abstract][Full Text] [Related]
23. NTCP-Reconstituted In Vitro HBV Infection System. Sun Y; Qi Y; Peng B; Li W Methods Mol Biol; 2017; 1540():1-14. PubMed ID: 27975303 [TBL] [Abstract][Full Text] [Related]
24. Hepatitis B Virus DNA Integration Occurs Early in the Viral Life Cycle in an Tu T; Budzinska MA; Vondran FWR; Shackel NA; Urban S J Virol; 2018 Jun; 92(11):. PubMed ID: 29437961 [TBL] [Abstract][Full Text] [Related]
25. A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide. Kaneko M; Watashi K; Kamisuki S; Matsunaga H; Iwamoto M; Kawai F; Ohashi H; Tsukuda S; Shimura S; Suzuki R; Aizaki H; Sugiyama M; Park SY; Ito T; Ohtani N; Sugawara F; Tanaka Y; Mizokami M; Sureau C; Wakita T J Virol; 2015 Dec; 89(23):11945-53. PubMed ID: 26378168 [TBL] [Abstract][Full Text] [Related]
26. Irbesartan, an FDA approved drug for hypertension and diabetic nephropathy, is a potent inhibitor for hepatitis B virus entry by disturbing Na(+)-dependent taurocholate cotransporting polypeptide activity. Wang XJ; Hu W; Zhang TY; Mao YY; Liu NN; Wang SQ Antiviral Res; 2015 Aug; 120():140-6. PubMed ID: 26086883 [TBL] [Abstract][Full Text] [Related]
27. Aborted infection of human sodium taurocholate cotransporting polypeptide (hNTCP) expressing woodchuck hepatocytes with hepatitis B virus (HBV). Yang L; Zhou D; Martin K; Wu J; Chen M; Lu M; Yang D; Protzer U; Roggendorf M; Song J Virus Genes; 2023 Dec; 59(6):823-830. PubMed ID: 37728707 [TBL] [Abstract][Full Text] [Related]
28. Sodium taurocholate cotransporting polypeptide acts as a receptor for hepatitis B and D virus. Yan H; Li W Dig Dis; 2015; 33(3):388-96. PubMed ID: 26045274 [TBL] [Abstract][Full Text] [Related]
29. Efficient long-term amplification of hepatitis B virus isolates after infection of slow proliferating HepG2-NTCP cells. König A; Yang J; Jo E; Park KHP; Kim H; Than TT; Song X; Qi X; Dai X; Park S; Shum D; Ryu WS; Kim JH; Yoon SK; Park JY; Ahn SH; Han KH; Gerlich WH; Windisch MP J Hepatol; 2019 Aug; 71(2):289-300. PubMed ID: 31077792 [TBL] [Abstract][Full Text] [Related]
30. From DCPD to NTCP: the long journey towards identifying a functional hepatitis B virus receptor. Li J; Tong S Clin Mol Hepatol; 2015 Sep; 21(3):193-9. PubMed ID: 26523264 [TBL] [Abstract][Full Text] [Related]
32. N-Linked Glycosylation Is Not Essential for Sodium Taurocholate Cotransporting Polypeptide To Mediate Hepatitis B Virus Infection Lee J; Zong L; Krotow A; Qin Y; Jia L; Zhang J; Tong S; Li J J Virol; 2018 Aug; 92(15):. PubMed ID: 29793953 [TBL] [Abstract][Full Text] [Related]
33. Efficient delivery of HBV NLS siRNAs into HepG2.2.15 cells for HBV inhibition through novel recombinant preS1‑tP proteins. Zeng Y; Li Z; Shang J; Kang Y Int J Mol Med; 2018 Aug; 42(2):1181-1189. PubMed ID: 29786106 [TBL] [Abstract][Full Text] [Related]
34. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Yan H; Zhong G; Xu G; He W; Jing Z; Gao Z; Huang Y; Qi Y; Peng B; Wang H; Fu L; Song M; Chen P; Gao W; Ren B; Sun Y; Cai T; Feng X; Sui J; Li W Elife; 2012 Nov; 3():. PubMed ID: 25409679 [TBL] [Abstract][Full Text] [Related]
35. Kinetics of the bile acid transporter and hepatitis B virus receptor Na+/taurocholate cotransporting polypeptide (NTCP) in hepatocytes. König A; Döring B; Mohr C; Geipel A; Geyer J; Glebe D J Hepatol; 2014 Oct; 61(4):867-75. PubMed ID: 24845614 [TBL] [Abstract][Full Text] [Related]
36. A new hepatoma cell line exhibiting high susceptibility to hepatitis B virus infection. Ueda Y; Gu W; Dansako H; Nishitsuji H; Satoh S; Shimotohno K; Kato N Biochem Biophys Res Commun; 2019 Jul; 515(1):156-162. PubMed ID: 31133379 [TBL] [Abstract][Full Text] [Related]
37. Inhibitory effect of fasiglifam on hepatitis B virus infections through suppression of the sodium taurocholate cotransporting polypeptide. Nio Y; Akahori Y; Okamura H; Watashi K; Wakita T; Hijikata M Biochem Biophys Res Commun; 2018 Jun; 501(3):820-825. PubMed ID: 29723527 [TBL] [Abstract][Full Text] [Related]
38. Spinoculation Enhances HBV Infection in NTCP-Reconstituted Hepatocytes. Yan R; Zhang Y; Cai D; Liu Y; Cuconati A; Guo H PLoS One; 2015; 10(6):e0129889. PubMed ID: 26070202 [TBL] [Abstract][Full Text] [Related]
39. Limited disassembly of cytoplasmic hepatitis B virus nucleocapsids restricts viral infection in murine hepatic cells. Zhao K; Guo F; Wang J; Zhong Y; Yi J; Teng Y; Xu Z; Zhao L; Li A; Wang Z; Chen X; Cheng X; Xia Y Hepatology; 2023 Apr; 77(4):1366-1381. PubMed ID: 35718932 [TBL] [Abstract][Full Text] [Related]